Antibiotic treatment in patients with sepsis: a narrative review.
Erika P Plata-MenchacaRicard FerrerJuan Carlos Ruiz RodríguezRui MoraisPaula FernandesPublished in: Hospital practice (1995) (2020)
Sepsis is a medical emergency and life-threatening condition due to a dysregulated host response to infection, with unacceptably high morbidity and mortality. Similar to acute myocardial infarction or cerebral vascular accident, sepsis is a severe and continuous time-dependent condition. Thus, in the case of sepsis, early and adequate administration of antimicrobials must be a priority, ideally within the first hour of diagnosis, simultaneously with organ support.As a consequence of the emergence of multidrug-resistant pathogens, the choice of antimicrobials should be performed according to the local pathogen patterns of resistance. Individual antimicrobial optimization is essential to achieve adequate concentrations of antimicrobials, to reduce adverse effects, and to ensure successful outcomes, as well as preventing the emergence of multidrug-resistant pathogens. The loading dose is the administration of an initial higher dose of antimicrobials, regardless of the presence of organ dysfunction. Further doses should be implemented according to pharmacokinetics/pharmacodynamics of antimicrobials and should be adjusted according to the presence of renal or liver dysfunction. Extended or continuous infusion of beta-lactams and therapeutic drug monitoring can help to achieve therapeutic levels of antimicrobials. Duration and adequacy of treatment must be reviewed at regular intervals to allow effective de-escalation and administration of short courses of antimicrobials for most patients. Antimicrobial stewardship frameworks, leadership, focus on the optimal duration of treatments, de-escalation, and novel diagnostic stewardship approaches will help us to improve patients the process of care and overall quality of care.
Keyphrases
- multidrug resistant
- healthcare
- end stage renal disease
- acute kidney injury
- acute myocardial infarction
- intensive care unit
- newly diagnosed
- chronic kidney disease
- ejection fraction
- palliative care
- septic shock
- prognostic factors
- heart failure
- drug resistant
- public health
- quality improvement
- patient reported outcomes
- adipose tissue
- staphylococcus aureus
- clinical trial
- acute coronary syndrome
- left ventricular
- pseudomonas aeruginosa
- combination therapy
- subarachnoid hemorrhage
- skeletal muscle
- metabolic syndrome
- early onset
- klebsiella pneumoniae
- decision making
- emergency medical